Simona Kavaliauskiene

Dr. Simona Kavaliauskiene

Group of "Cardiaomyocyte function in health & disease", Institute for Experimental Medical Research, University of Oslo, 0450 Oslo, Norway
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2018 in Histochemistry and Cell Biology
Verified
Journal Article
Open access
PDF file
KSKirsten Sandvig
Kirsten Sandvig
SKSimona Kavaliauskiene
Simona Kavaliauskiene
TSTore Skotland
Tore Skotland
This article aims at providing an update on the complexity of clathrin-independent endocytosis. It is now almost 30 years since we first wrote a review about its existence; at that time many people believed that with the exception of macropinocytosis, which will only be briefly mentioned in this review, all uptake could be accounted for by clathrin-dependent endocytosis. Now it is generally accepted that there are different clathrin-independent mechanisms, some of them regulated by ligands and membrane lipid composition. They can be both dynamin-dependent and -independent, meaning that the uptake cannot be accounted for by caveolae and other dynamin-dependent processes such as tubular structures that can be induced by toxins, e.g. Shiga toxin, or the fast endophilin mediated endocytosis recently described. Caveolae seem to be mostly quite stable structures with other functions than endocytosis, but evidence suggests that they may have cell-type dependent functions. Although several groups have been working on endocytic mechanisms for years, and new advanced methods have improved our ability to study mechanistic details, there are still a number of important questions we need to address, such as: How many endocytic mechanisms does a cell have? How quantitatively important are they? What about the complexity in polarized cells where clathrin-independent endocytosis is differentially regulated on the apical and basolateral poles? These questions are not easy to answer since one and the same molecule may contribute to more than one process, and manipulating one mechanism can affect another. Also, several inhibitors of endocytic processes commonly used turn out to be less specific than originally thought. We will here describe the current view of clathrin-independent endocytic processes and the challenges in studying them.

1 April 2014 in Progress in Lipid Research
Verified
Journal Article
Closed access
KSKirsten Sandvig
Kirsten Sandvig
JBJonas Bergan
Jonas Bergan
SKSimona Kavaliauskiene
Simona Kavaliauskiene
TSTore Skotland
Tore Skotland

20 April 2020 in Cancer and Metastasis Reviews
Verified
Journal Article
Open access
PDF file
TSTore Skotland
Tore Skotland
SKSimona Kavaliauskiene
Simona Kavaliauskiene
KSKirsten Sandvig
Kirsten Sandvig
Several studies have demonstrated interactions between the two leaflets in membrane bilayers and the importance of specific lipid species for such interaction and membrane function. We here discuss these investigations with a focus on the sphingolipid and cholesterol-rich lipid membrane domains called lipid rafts, including the small flask-shaped invaginations called caveolae, and the importance of such membrane structures in cell biology and cancer. We discuss the possible interactions between the very long-chain sphingolipids in the outer leaflet of the plasma membrane and the phosphatidylserine species PS 18:0/18:1 in the inner leaflet and the importance of cholesterol for such interactions. We challenge the view that lipid rafts contain a large fraction of lipids with two saturated fatty acyl groups and argue that it is important in future studies of membrane models to use asymmetric membrane bilayers with lipid species commonly found in cellular membranes. We also discuss the need for more quantitative lipidomic studies in order to understand membrane function and structure in general, and the importance of lipid rafts in biological systems. Finally, we discuss cancer-related changes in lipid rafts and lipid composition, with a special focus on changes in glycosphingolipids and the possibility of using lipid therapy for cancer treatment.

3 February 2017 in Toxins
Verified
Journal Article
Open access
PDF file
SKSimona Kavaliauskiene
Simona Kavaliauskiene
ALAnne Berit Dyve Lingelem
Anne Berit Dyve Lingelem
TSTore Skotland
Tore Skotland
KSKirsten Sandvig
Kirsten Sandvig
Shiga toxins consist of an A-moiety and five B-moieties able to bind the neutral glycosphingolipid globotriaosylceramide (Gb3) on the cell surface. To intoxicate cells efficiently, the toxin A-moiety has to be cleaved by furin and transported retrogradely to the Golgi apparatus and to the endoplasmic reticulum. The enzymatically active part of the A-moiety is then translocated to the cytosol, where it inhibits protein synthesis and in some cell types induces apoptosis. Protection of cells can be provided either by inhibiting binding of the toxin to cells or by interfering with any of the subsequent steps required for its toxic effect. In this article we provide a brief overview of the interaction of Shiga toxins with cells, describe some compounds and conditions found to protect cells against Shiga toxins, and discuss whether they might also provide protection in animals and humans.

25 May 2021 in Toxins
Verified
Journal Article
Open access
PDF file
KSKirsten Sandvig
Kirsten Sandvig
SKSimona Kavaliauskiene
Simona Kavaliauskiene
TSTore Skotland
Tore Skotland
Protein toxins secreted by bacteria and found in plants can be threats to human health. However, their extreme toxicity can also be exploited in different ways, e.g., to produce hybrid toxins directed against cancer cells and to study transport mechanisms in cells. Investigations during the last decades have shown how powerful these molecules are as tools in cell biological research. Here, we first present a partly historical overview, with emphasis on Shiga toxin and ricin, of how such toxins have been used to characterize processes and proteins of importance for their trafficking. In the second half of the article, we describe how one can now use toxins to investigate the role of lipid classes for intracellular transport. In recent years, it has become possible to quantify hundreds of lipid species using mass spectrometry analysis. Thus, it is also now possible to explore the importance of lipid species in intracellular transport. The detailed analyses of changes in lipids seen under conditions of inhibited toxin transport reveal previously unknown connections between syntheses of lipid classes and demonstrate the ability of cells to compensate under given conditions.

1 October 2011 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PJPetras Juzenas
Petras Juzenas
SSSimona Steponkiene
Simona Steponkiene
SKSimona Kavaliauskiene
Simona Kavaliauskiene
RPRasa Purviniene
Rasa Purviniene
RRRicardas Rotomskis
Ricardas Rotomskis
Peer reviewed article authored by (Steponkiene S, Kavaliauskiene S, Purviniene R, Rotomskis R, Juzenas P). Read article or submit your manuscript for publishing.